These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24236141)

  • 1. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
    Troeung L; Egan SJ; Gasson N
    PLoS One; 2013; 8(11):e79510. PubMed ID: 24236141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
    Pontone GM; Mills KA
    Am J Geriatr Psychiatry; 2021 Jun; 29(6):530-540. PubMed ID: 33648830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotherapy for the Treatment of Anxiety and Depression in Patients with Parkinson Disease: A Meta-Analysis of Randomized Controlled Trials.
    Hong CT; Tan S; Huang TW
    J Am Med Dir Assoc; 2021 Nov; 22(11):2289-2295.e2. PubMed ID: 33957132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural activation therapy for depression in adults.
    Uphoff E; Ekers D; Robertson L; Dawson S; Sanger E; South E; Samaan Z; Richards D; Meader N; Churchill R
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013305. PubMed ID: 32628293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for depression and anxiety in Parkinson's disease.
    Yang S; Sajatovic M; Walter BL
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment.
    Chen J; He P; Zhang Y; Gao Y; Qiu Y; Li Y; Zhang Q; Wang L; Huang Z; Zhao J; Nie K; Wang L
    Int J Neurosci; 2021 Apr; 131(4):411-424. PubMed ID: 32253965
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-Behavioral Therapy for Anxiety in Parkinson's Disease.
    Reynolds GO; Saint-Hilaire M; Thomas CA; Barlow DH; Cronin-Golomb A
    Behav Modif; 2020 Jul; 44(4):552-579. PubMed ID: 30931594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: A systematic review and meta-analysis.
    Zhang Q; Yang X; Song H; Jin Y
    Complement Ther Clin Pract; 2020 May; 39():101111. PubMed ID: 32379650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease.
    Egan SJ; Laidlaw K; Starkstein S
    J Parkinsons Dis; 2015; 5(3):443-51. PubMed ID: 26406124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote delivery of psychological interventions for Parkinson's disease.
    Swalwell C; Pachana NA; Dissanayaka NN
    Int Psychogeriatr; 2018 Dec; 30(12):1783-1795. PubMed ID: 29747712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for treating anxiety after stroke.
    Knapp P; Campbell Burton CA; Holmes J; Murray J; Gillespie D; Lightbody CE; Watkins CL; Chun HY; Lewis SR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD008860. PubMed ID: 28535332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review.
    Angelopoulou E; Stanitsa E; Karpodini CC; Bougea A; Kontaxopoulou D; Fragkiadaki S; Koros C; Georgakopoulou VE; Fotakopoulos G; Koutedakis Y; Piperi C; Papageorgiou SG
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.
    Leentjens AF
    Drugs; 2011 Feb; 71(3):273-86. PubMed ID: 21319866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for self-harm in children and adolescents.
    Hawton K; Witt KG; Taylor Salisbury TL; Arensman E; Gunnell D; Townsend E; van Heeringen K; Hazell P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD012013. PubMed ID: 26688129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.